Wide Ranks

CERT

Certara, Inc.

11.27

Top Statistics
Market Cap 1 B Forward PE 22.40 Revenue Growth 10.80 %
Current Ratio 2.86 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -8.34 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 23.86 Enterprise / Revenue 5.07 Price To Sales Trailing12 Months 4.87
Profitability
Profit Margins -8.34 % Operating Margins 6.74 %
Balance Sheet
Total Cash 235 M Total Cash Per Share 1.46 Total Debt 311 M
Total Debt To Equity 29.53 Current Ratio 2.86 Book Value Per Share 6.55
All Measures
Short Ratio 422.00 % Message Board Id finmb_100474847 Shares Short Prior Month 4 M
Return On Equity -0.0295 City Princeton Uuid 5d2cfab8-3ed6-386a-8812-690790dc7ad5
Previous Close 10.93 First Trade Date Epoch Utc 1 B Book Value 6.55
Beta 1.51 Total Debt 311 M Volume 687911
Price To Book 1.72 Fifty Two Week Low 9.41 Total Cash Per Share 1.46
Total Revenue 372 M Shares Short Previous Month Date 1 B Target Median Price 15.00
Max Age 86400 Recommendation Mean 2.27 Sand P52 Week Change 0.3133
Operating Margins 6.74 % Target Mean Price 14.28 Net Income To Common -31084000
Short Percent Of Float 0.0410 Implied Shares Outstanding 160 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 1 M Average Volume10days 1 M
Total Cash 235 M Next Fiscal Year End 1 B Revenue Per Share 2.33
Held Percent Insiders 0.0260 Ebitda Margins 21.24 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Regular Market Previous Close 10.93
Target Low Price 12.00 Gmt Off Set Milliseconds -18000000 Fifty Day Average 10.81
Open 11.02 Free Cashflow 70 M State NJ
Dividend Yield 0.00 % Return On Assets 0.0059 Time Zone Short Name EST
Trailing Eps -0.2000 Day Low 10.93 Address1 100 Overlook Center
Shares Outstanding 160 M Price Hint 2 Target High Price 17.00
Website https://www.certara.com 52 Week Change -0.2179 Average Volume 1 M
Forward Eps 0.5000 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 278.50 % Is_sp_500 False Regular Market Day High 11.32
Profit Margins -8.34 % Debt To Equity 29.53 Fifty Two Week High 19.87
Day High 11.32 Shares Short 4 M Regular Market Open 11.02
Industry Key health-information-services Earnings Growth 0.00 % Enterprise To Revenue 5.07
Revenue Growth 10.80 % Shares Percent Shares Out 0.0308 Operating Cashflow 54 M
Currency USD Time Zone Full Name America/New_York Market Cap 1 B
Is_nasdaq_100 False Zip 08540 Quote Type EQUITY
Industry Health Information Services Long Name Certara, Inc. Regular Market Day Low 10.93
Held Percent Institutions 0.9594 Current Price 11.27 Address2 Suite 101
Enterprise To Ebitda 23.86 Financial Currency USD Current Ratio 2.86
Gross Margins 59.68 % Industry Disp Health Information Services Number Of Analyst Opinions 9
Country United States Float Shares 110 M Two Hundred Day Average 14.44
Enterprise Value 1 B Price To Sales Trailing12 Months 4.87 Forward PE 22.40
Regular Market Volume 687911 Ebitda 79 M Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally.

It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

The company provides Simcyp Simulator, a mechanistic biosimulation platform mechanistic biosimulation investigational new drug and translational stages; Simcyp Biopharmaceutics, used to identify and refine drug formulations; and Simcyp Secondary Intelligence which integrates toxicology with quantitative analysis of networks of molecular and functional biological changes to identify drug toxicity and adverse drug reactions.

In addition, it offers Phoenix WinNonlin, a platform for non-compartmental analysis, pharmacokinetic/pharmacodynamic, and toxicokinetic; phoenix hosted, that provides a secured and validated certara amazon web services workspace; Phoenix NLME, a population modeling and simulation software for nonlinear mixed effects models; and pirana modeling workbench.

Further, the company provides pinnacle 21, a cloud-based platform for clinical data automation, standardization, and validation; Pinnacle 21 Data Exchange, used to define data standards and specifications; and Metadata Repository, to enable study design using controlled and standardized data.

It serves life sciences companies, biopharmaceutical companies, research organizations, academic institutions, and global regulators, as well as animal health, crop science, bio science, medical devices, and public sector industries.

Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.